Monte Rosa Market Risk Adjusted Performance

GLUE Stock  USD 4.58  0.23  5.29%   
Monte Rosa market-risk-adjusted-performance technical analysis lookup allows you to check this and other technical indicators for Monte Rosa Therapeutics or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also Equity Screeners to view more equity screening tools
Monte Rosa Therapeutics has current Market Risk Adjusted Performance of 0.126.

MRAP

 = 

ER[a] + (1/BETA - 1)

X

ER[a] - RFR)

 = 
0.126
ER[a] = Expected return on investing in Monte Rosa
RFR = Risk Free Rate of return. Typically T-Bill Rate
BETA = Beta of the asset with market or selected benchmark.

Monte Rosa Market Risk Adjusted Performance Peers Comparison

Monte Market Risk Adjusted Performance Relative To Other Indicators

Monte Rosa Therapeutics is rated # 4 in market risk adjusted performance category among its peers. It is currently under evaluation in maximum drawdown category among its peers reporting about  156.60  of Maximum Drawdown per Market Risk Adjusted Performance. The ratio of Maximum Drawdown to Market Risk Adjusted Performance for Monte Rosa Therapeutics is roughly  156.60 
Compare Monte Rosa to Peers

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas